Large insurance sales agency call centers are accused of enrolling individuals in plans without consent; more young adults are choosing permanent contraception procedures; widespread frustration with prior authorization requirements hints at potential future measures.
Lawsuit Alleges Scheme of Unauthorized Health Insurance Enrollment
A lawsuit filed in US District Court for the Southern District of Florida alleged that large insurance sales agency call centers engaged in a moneymaking scheme by enrolling individuals into Affordable Care Act (ACA) plans or switching their coverage without their permission, according to Kaiser Health News. The lawsuit claimed that call centers purchased names of individuals from misleading advertisements, leading to unauthorized enrollment or coverage switches. Consumers affected by the alleged scheme, which the suit said targeted low-income individuals, faced disruptions in access to health care providers and medications, as well as financial costs.
Increased Tubal Ligations and Vasectomies Among Young Adults After Roe v Wade Reversal
There has been a significant rise in tubal ligations and vasectomies among young adults in the US following the reversal of Roe v Wade, according to CNN. Researchers observed a notable increase in both tubal ligations and vasectomies among individuals aged 18 to 30 years, with tubal ligations showing twice the rate of increase compared with vasectomies. Experts have expressed concerns about the pressure young people face in making decisions regarding permanent contraception and emphasized the importance of informed decision-making and supportive health care environments.
CMS Considers Further Action on Health Insurance Prior Authorization
CMS is evaluating additional steps to address dissatisfaction with prior authorization, while emphasizing the need for collaboration with the private sector, according to Modern Healthcare. CMS Administrator Chiquita Brooks-LaSure acknowledged the widespread frustration with prior authorization requirements at the American Hospital Association's annual conference in Washington, DC, on Monday. Brooks-LaSure indicated that the agency is open to further action, particularly in response to concerns regarding prescription drugs.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More
2 Commerce Drive
Cranbury, NJ 08512